Embracing Diversity & Inclusion
-
3 Ways The FDA Is Taking Action On Lack Of Diversity In Cancer Clinical Trials
3/3/2022
Beyond issuing guidance documents, what actions has the FDA taken to ensure inclusion of relevant patient populations in cancer clinical trials? And what has been the impact? This article outlines three observations regarding the agency's recent efforts.
-
Patient Diversity In Clinical Studies: The Key To Advancing Precision Medicine
2/22/2022
Until we have better inclusion of participants with diverse demographics and behaviors – and can analyze that data – we won’t know the effectiveness of a product for these patients. This article shares the barriers to patient diversity in traditional studies, the efforts that the authors' company is putting forth, and considerations to keep in mind.
-
Fixing The Patient Data Collection Process To Solve Bias In Precision Medicine
2/17/2022
A big problem in personalized medicine is that existing data overwhelmingly represents people of European descent, so a machine learning model built on such data sets can be fundamentally biased. However, it is often the data — not the algorithms — that are the root cause of the issues. These authors decided to look into fixing the processes that collect the data.
-
Sex Matters… In Preclinical Drug Development?
1/18/2022
In safety pharmacology studies investigating short-term side effects on physiological functions, the scientist is obliged to “consider” sex in the study design of animal models. This article also shares the differences in anxiety and depression in human males and females.
-
Diversity In Clinical Trials: Recent Efforts From The MedTech Color Collaborative
12/7/2021
Earlier this year, the MedTech Color Collaborative was created with a goal of convening a diverse cross-section of industry stakeholders to work together to identify issues and opportunities for improvement in this critical space. The group shares and curates existing knowledge and strives to develop evidence-based solutions and best practices to address the health inequities facing minorities.
-
The BRAAVE 2020 Study: Engaging Black American Communities In HIV Clinical Research
10/28/2021
Black Americans are disproportionately impacted by HIV and have the highest rates of new HIV infections every year compared to other racial groups in the U.S. This article shares Gilead Sciences' methodology for a Phase 3 clinical trial for engaging patients living with HIV who self-identified as Black, African American, or mixed race.
-
What Can Clinical Leaders Do To Tackle The Global Women’s Health Gap?
9/9/2021
Nearly 300,000 women die every year from preventable causes related to pregnancy and childbirth. Postpartum hemorrhage is the leading cause of maternal death globally — and in the US, it's on the rise. Uterine fibroids disproportionately impact Black women and are a leading cause of hysterectomies. We must drive a concerted, ecosystem-wide effort that scales up clinical research for women.
-
Tackling Health Misinformation Among Hispanics For Better Clinical Research & Patient Data
8/31/2021
For years, Hispanic communities have faced inequities in many aspects of healthcare — from finding health education, being health literate, accessing healthcare, and underrepresentation in clinical research. This article discusses CreakyJoints' efforts in tackling this health misinformation.
-
Diversity In Clinical Trials: 10 Strategies To Increase Minority Enrollment In Oncology Trials
7/20/2021
Ethnicity, age, and sex can all impact safety and efficacy of any medication in people. Hence, diversity among clinical trial participants is critically important. This article shares 10 interventions to ensure participation of underserved groups to enhance diverse clinical recruitment.
-
How To Increase Patient Diversity: LLS Brings Clinical Trials To Underrepresented Communities
6/10/2021
Racial and ethnic minorities, rural residents, and people with lower socioeconomic status are overwhelmingly underrepresented in clinical trials. The Leukemia & Lymphoma Society (LLS) has launched a first-of-its-kind research grant program to help move the needle on this long-standing problem.